| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| HTR1A | HTR2A | ENSBTAP00000048502 | ENSBTAP00000017943 | 5-hydroxytryptamine receptor 1A. | 5-hydroxytryptamine receptor 2A; G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various drugs and psychoactive substances, including mescaline, psilocybin, 1-(2,5- dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Beta-arrestin family members inhibit signaling via G proteins and mediate activation of alternative signaling pathways. S [...] | 0.609 |
| HTR1A | MAOA | ENSBTAP00000048502 | ENSBTAP00000021570 | 5-hydroxytryptamine receptor 1A. | Amine oxidase [flavin-containing] A; Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues. MAOA preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT), norepinephrine and epinephrine. | 0.495 |
| HTR1A | MAOB | ENSBTAP00000048502 | ENSBTAP00000001698 | 5-hydroxytryptamine receptor 1A. | Amine oxidase [flavin-containing] B; Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues. MAOB preferentially degrades benzylamine and phenylethylamine (By similarity); Belongs to the flavin monoamine oxidase family. | 0.423 |
| HTR1A | SLC6A4 | ENSBTAP00000048502 | ENSBTAP00000067324 | 5-hydroxytryptamine receptor 1A. | Sodium-dependent serotonin transporter; Serotonin transporter whose primary function in the central nervous system involves the regulation of serotonergic signaling via transport of serotonin molecules from the synaptic cleft back into the pre-synaptic terminal for re-utilization. Plays a key role in mediating regulation of the availability of serotonin to other receptors of serotonergic systems. Terminates the action of serotonin and recycles it in a sodium-dependent manner. | 0.729 |
| HTR1A | TPH1 | ENSBTAP00000048502 | ENSBTAP00000007030 | 5-hydroxytryptamine receptor 1A. | Tryptophan hydroxylase 1. | 0.496 |
| HTR1B | HTR1D | ENSBTAP00000053759 | ENSBTAP00000049912 | 5-hydroxytryptamine receptor 1B. | 5-hydroxytryptamine receptor 1D. | 0.577 |
| HTR1B | HTR2A | ENSBTAP00000053759 | ENSBTAP00000017943 | 5-hydroxytryptamine receptor 1B. | 5-hydroxytryptamine receptor 2A; G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various drugs and psychoactive substances, including mescaline, psilocybin, 1-(2,5- dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Beta-arrestin family members inhibit signaling via G proteins and mediate activation of alternative signaling pathways. S [...] | 0.626 |
| HTR1B | HTR2B | ENSBTAP00000053759 | ENSBTAP00000052700 | 5-hydroxytryptamine receptor 1B. | 5-hydroxytryptamine receptor 2B. | 0.554 |
| HTR1B | MAOA | ENSBTAP00000053759 | ENSBTAP00000021570 | 5-hydroxytryptamine receptor 1B. | Amine oxidase [flavin-containing] A; Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues. MAOA preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT), norepinephrine and epinephrine. | 0.475 |
| HTR1B | SLC18A2 | ENSBTAP00000053759 | ENSBTAP00000006221 | 5-hydroxytryptamine receptor 1B. | Synaptic vesicular amine transporter; Involved in the ATP-dependent vesicular transport of biogenic amine neurotransmitters. Pumps cytosolic monoamines including dopamine, norepinephrine, serotonin, and histamine into synaptic vesicles. Requisite for vesicular amine storage prior to secretion via exocytosis. | 0.451 |
| HTR1B | SLC6A4 | ENSBTAP00000053759 | ENSBTAP00000067324 | 5-hydroxytryptamine receptor 1B. | Sodium-dependent serotonin transporter; Serotonin transporter whose primary function in the central nervous system involves the regulation of serotonergic signaling via transport of serotonin molecules from the synaptic cleft back into the pre-synaptic terminal for re-utilization. Plays a key role in mediating regulation of the availability of serotonin to other receptors of serotonergic systems. Terminates the action of serotonin and recycles it in a sodium-dependent manner. | 0.729 |
| HTR1B | TPH1 | ENSBTAP00000053759 | ENSBTAP00000007030 | 5-hydroxytryptamine receptor 1B. | Tryptophan hydroxylase 1. | 0.611 |
| HTR1D | HTR1B | ENSBTAP00000049912 | ENSBTAP00000053759 | 5-hydroxytryptamine receptor 1D. | 5-hydroxytryptamine receptor 1B. | 0.577 |
| HTR1D | SLC6A4 | ENSBTAP00000049912 | ENSBTAP00000067324 | 5-hydroxytryptamine receptor 1D. | Sodium-dependent serotonin transporter; Serotonin transporter whose primary function in the central nervous system involves the regulation of serotonergic signaling via transport of serotonin molecules from the synaptic cleft back into the pre-synaptic terminal for re-utilization. Plays a key role in mediating regulation of the availability of serotonin to other receptors of serotonergic systems. Terminates the action of serotonin and recycles it in a sodium-dependent manner. | 0.697 |
| HTR1D | TPH1 | ENSBTAP00000049912 | ENSBTAP00000007030 | 5-hydroxytryptamine receptor 1D. | Tryptophan hydroxylase 1. | 0.528 |
| HTR2A | HTR1A | ENSBTAP00000017943 | ENSBTAP00000048502 | 5-hydroxytryptamine receptor 2A; G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various drugs and psychoactive substances, including mescaline, psilocybin, 1-(2,5- dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Beta-arrestin family members inhibit signaling via G proteins and mediate activation of alternative signaling pathways. S [...] | 5-hydroxytryptamine receptor 1A. | 0.609 |
| HTR2A | HTR1B | ENSBTAP00000017943 | ENSBTAP00000053759 | 5-hydroxytryptamine receptor 2A; G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various drugs and psychoactive substances, including mescaline, psilocybin, 1-(2,5- dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Beta-arrestin family members inhibit signaling via G proteins and mediate activation of alternative signaling pathways. S [...] | 5-hydroxytryptamine receptor 1B. | 0.626 |
| HTR2A | HTR2B | ENSBTAP00000017943 | ENSBTAP00000052700 | 5-hydroxytryptamine receptor 2A; G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various drugs and psychoactive substances, including mescaline, psilocybin, 1-(2,5- dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Beta-arrestin family members inhibit signaling via G proteins and mediate activation of alternative signaling pathways. S [...] | 5-hydroxytryptamine receptor 2B. | 0.932 |
| HTR2A | MAOA | ENSBTAP00000017943 | ENSBTAP00000021570 | 5-hydroxytryptamine receptor 2A; G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various drugs and psychoactive substances, including mescaline, psilocybin, 1-(2,5- dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Beta-arrestin family members inhibit signaling via G proteins and mediate activation of alternative signaling pathways. S [...] | Amine oxidase [flavin-containing] A; Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues. MAOA preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT), norepinephrine and epinephrine. | 0.656 |
| HTR2A | MAOB | ENSBTAP00000017943 | ENSBTAP00000001698 | 5-hydroxytryptamine receptor 2A; G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various drugs and psychoactive substances, including mescaline, psilocybin, 1-(2,5- dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Beta-arrestin family members inhibit signaling via G proteins and mediate activation of alternative signaling pathways. S [...] | Amine oxidase [flavin-containing] B; Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues. MAOB preferentially degrades benzylamine and phenylethylamine (By similarity); Belongs to the flavin monoamine oxidase family. | 0.503 |